Linnainmaa K - National Institutes of Health
Mesothelioma Cancer Expert at National Institutes of Health, Bethesda, MD
Mesothelioma Cancer Expert - Linnainmaa K - Current Listing of Published Papers
The following is a listing of research papers by Linnainmaa K in the field of mesothelioma cancer.
Articles written by Linnainmaa K
| Knuuttila A, Ollikainen T, Halme M, Mali P, Kivisaari L, Linnainmaa K, Jekunen A, Mattson K. Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma–a feasibility study. Anticancer Drugs. 2000 Apr;11(4):257-61. Pubmed 10898540 Department of Medicine, Helsinki University Central Hospital, Finland. [hus.fi] |
| Nygren J, Suhonen S, Norppa H, Linnainmaa K. DNA damage in bronchial epithelial and mesothelial cells with and without associated crocidolite asbestos fibers. Environ Mol Mutagen. 2004;44(5):477-82. Pubmed 15534864 Laboratory of Molecular and Cellular Toxicology, Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Hirvonen A, Tuimala J, Ollikainen T, Linnainmaa K, Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett. 2002 Apr 8;178(1):71-4. Pubmed 11849743 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, FIN-00250 Helsinki, Finland. [occuphealth.fi] |
| Pylkkanen L, Sainio M, Ollikainen T, Mattson K, Nordling S, Carpen O, Linnainmaa K, Husgafvel-Pursiainen K. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region. Oncol Rep. 2002 Sep-Oct;9(5):955-9. Pubmed 12168054 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Kettunen E, Nissen AM, Ollikainen T, Taavitsainen M, Tapper J, Mattson K, Linnainmaa K, Knuutila S, El-Rifai W. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int J Cancer. 2001 Feb 15;91(4):492-6. Pubmed 11251971 Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, FIN-00029 HUCH, Helsinki, Finland. |
| Kahlos K, Soini Y, Sormunen R, Kaarteenaho-Wiik R, Paakko P, Linnainmaa K, Kinnula VL. Expression and prognostic significance of catalase in malignant mesothelioma. Cancer. 2001 Apr 1;91(7):1349-57. Pubmed 11283936 Department of Internal Medicine, University of Oulu, FIN-90220, Oulu, Finland. |
| Jarvinen K, Pietarinen-Runtti P, Linnainmaa K, Raivio KO, Krejsa CM, Kavanagh T, Kinnula VL. Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol. 2000 Apr;278(4):L696-702. Pubmed 10749746 Childrens Hospital, University of Helsinki, 00029 Helsinki, 90220 Oulu Finland. |
| Ollikainen T, Knuuttila A, Suhonen S, Taavitsainen M, Jekunen A, Mattson K, Linnainmaa K. In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anticancer Drugs. 2000 Feb;11(2):93-9. Pubmed 10789591 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki. [occuphealth.fi] |
| Kahlos K, Soini Y, Paakko P, Saily M, Linnainmaa K, Kinnula VL. Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma. Int J Cancer. 2000 Oct 1;88(1):37-43. Pubmed 10962437 Department of Internal Medicine, University of Oulu, Oulu, Finland. [oulu.fi] |
| Soini Y, Kinnula V, Kaarteenaho-Wiik R, Kurttila E, Linnainmaa K, Paakko P. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Clin Cancer Res. 1999 Nov;5(11):3508-15. Pubmed 10589765 Department of Pathology, University of Oulu and Oulu University Hospital, Finland. |
| Xu L, Flynn BJ, Ungar S, Pass HI, Linnainmaa K, Mattson K, Gerwin BI. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis. 1999 May;20(5):773-83. Pubmed 10334193 Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD 20892, USA. |
| Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M, Linnainmaa K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog. 1999 Oct;26(2):93-9. Pubmed 10506753 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Kahlos K, Pitkanen S, Hassinen I, Linnainmaa K, Kinnula VL. Generation of reactive oxygen species by human mesothelioma cells. Br J Cancer. 1999 Apr;80(1-2):25-31. Pubmed 10389973 Department of Internal Medicine, University of Oulu, Finland. |
| Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res. 1998 Oct 15;58(20):4505-9. Pubmed 9788590 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. |
| Kinnula VL, Linnala A, Viitala E, Linnainmaa K, Virtanen I. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. Am J Respir Cell Mol Biol. 1998 Sep;19(3):445-52. Pubmed 9730872 Department of Internal Medicine, University of Oulu, Oulu; Department of Anatomy, Institute of Biomedicine, University of Helsinki; and Finnish Institute of Occupational Health, Helsinki, Finland. [oulu.fi] |
| Kinnula K, Linnainmaa K, Raivio KO, Kinnula VL. Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity. Br J Cancer. 1998 Apr;77(7):1097-102. Pubmed 9569045 Finnish Institute of Occupational Health, Children’s Hospital, University of Helsinki. |
| Kahlos K, Anttila S, Asikainen T, Kinnula K, Raivio KO, Mattson K, Linnainmaa K, Kinnula VL. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol. 1998 Apr;18(4):570-80. Pubmed 9533946 Department of Internal Medicine, University of Oulu, Oulu, Finland. |
